10 results

• GLP-1 Diabetes Drugs Linked to Increased Risk of Kidney Side Effects

  January 29, 2026

  Irvin Jackson

  A new study finds that GLP-1 medications carry higher risks of long-term kidney damage than drugs like Invokana and Jardiance.

• Ozempic Side Effects Led to Severe Vision Loss, Lawsuit Claims

  January 21, 2026

  Irvin Jackson

  A recent Ozempic NAION lawsuit claims Novo Nordisk knew the drug was linked to vision loss risks for years, but failed to update the label warnings.

• Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference

  January 13, 2026

  Irvin Jackson

  Parties involved with Ozempic blindness lawsuits will meet with a federal judge overseeing the litigation for the first time on January 13.

• Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL

  December 18, 2025

  Irvin Jackson

  All Ozempic and Wegovy vision loss lawsuits have been consolidated before the same federal judge overseeing related claims alleging stomach paralysis linked to the medications.

• Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects

  November 26, 2025

  Russell Maas

  An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation.

• Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue

  October 7, 2025

  Irvin Jackson

  Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation.

• Reports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s

  October 3, 2025

  Irvin Jackson

  Reports of “Ozempic teeth” are growing, as dentists warn GLP-1 medications may cause bad breath, dental erosion and other oral health issues.

• MDL Sought for GLP-1 NAION Lawsuits Against Ozempic, Wegovy, Mounjaro Manufacturers

  August 29, 2025

  Irvin Jackson

  Eli Lilly seeks to consolidate all GLP-1 vision loss lawsuits into a new MDL, and assign them to the same court where the drugs' gastroparesis injury cases are being held.

• GLP-1 Vision Loss Risks Extend Beyond Type 2 Diabetics and Ozempic Users, Study Warns

  August 6, 2025

  Irvin Jackson

  New research suggests that vision problems are not restricted to just Ozempic, but may be a risk faced by all GLP-1 medication users.

• Pancreatitis Risks From Ozempic, Mounjaro Being Investigated by U.K. Regulators

  July 15, 2025

  Irvin Jackson

  U.K. health regulators are urging users of drugs like Ozempic and Mounjaro to report cases of acute pancreatitis as part of an ongoing genetic investigation.